Prereferral Treatment of Head and Neck Cancer Patients Disregards Guidelines
New findings indicate that prereferral care does not conform to clinical practice guidelines in nearly half of patients with head and neck cancer who are referred to a tertiary care center with persistent or recurrent disease, new findings indicate.
Excessive Optimism Plagues Early Cancer Studies
New data suggest that unrealistic optimism is common in patients who participate in early-phase cancer clinical trials and may interfere with their ability to provide informed consent.
Exercise Routine Recommended for Prostate Cancer Survivors
Researchers are calling for prostate cancer survivors to incorporate physical activity into their daily routine.
ASCO GI Coverage: Delaying Chemotherapy Increases the Mortality Risk of Patients with Colon Cancer
The results of a systematic review and meta-analysis suggest that the mortality risk for colon cancer patients begins to increase with any avoidable delay in adjuvant chemotherapy beyond 4 weeks.
Intensive Chemotherapy Boosts Prognosis in Older Teens With Acute Lymphoblastic Leukemia
New data demonstrate that older adolescents with acute lymphoblastic leukemia (ALL) can be cured using risk-adjusted intensive chemotherapy without prophylactic cranial irradiation or routine stem cell transplantation.
ASCO GI Coverage: Everolimus Associated With Significant PFS Improvement in Patients With PNETs
Data from a large randomized trial showed that treatment with the targeted agent everolimus was associated with a 65% improvement in progression-free survival (PFS) in patients with advanced pancreatic neuroendocrine tumors (PNETs).
Cancer as a Chronic Condition Implications for Practice
Articles on cancer as a chronic condition often include an account of a patient's journey from diagnosis to present day.
False-Positive Mammograms Lead to Anxiety and Quality-of-Life Issues
A false-positive result on a mammogram may trigger anxiety and decrease quality of life, and the effects may remain apparent a year later, new data suggest.
Breastfeeding May Benefit Childhood Cancer Survivors
For women who have survived childhood cancer, breastfeeding may help counter some of the long-term complications that occur as a result of their prior cancer treatments, researchers say.
Therapy Class Review: Blood Modifiers
In reviewing the therapeutic category of blood modifiers, there are 3 areas of focus
Mission Possible: Managing Specialty Pharmacy Costs and Utilization
To get the right drug in the right amount at the right time to the patient in the most cost-effective manner
ASCO GI Coverage: Women Who Use Bisphosphonates for Osteoporosis Reduce Their Risk of Colorectal Cancer
The risk of colorectal cancer declined by 33% among postmenopausal women taking oral bisphosphonates for osteoporosis
ASCO GI Coverage: Australian Study Finds ISH to Be the Best Assessor of HER2 Expression in Gastric Cancer
In situ hybridization (ISH) yields the best results for assessing HER2 expression in gastric cancer, according to a multilaboratory analysis of testing methods.
ASCO GI Coverage: Study Finds Tumor Characteristics Correlate With Survival in Stomach, Esophageal Cancers
An analysis of the National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database showed that advanced gastric or esophageal cancer confers a poor prognosis
ASCO GI Coverage: Imatinib Trough Levels Remain Stable in Most Advanced GIST Patients During Long-Term Treatment
Patients with gastrointestinal stromal tumors (GIST) had stable plasma concentrations of imatinib during long-term treatment, reported Yoon-Koo Kang, MD, PhD, and colleagues at the Gastrointestinal Cancers Symposium.
ASCO GI Coverage: European Study Shows Bevacizumab to Be Ineffective as Adjuvant Therapy
The results of a large, multicenter trial showed that the addition of bevacizumab to adjuvant chemotherapy failed to improve disease-free survival (DFS) compared with chemotherapy alone.
ASCO GI Interview Series: Robert Rosenberg, MD, Discusses Advantages of ColoPrint Test
At the 2011 symposium in San Francisco, California, Oncology & Biotech News spoke with the author of one of the featured presentations at the meeting
ASCO GI Interview Series: Improving Patient Outcomes in Pancreatic Cancer: A Conversation with Mitchell C. Posner, MD
Few cancers have a bleaker outlook than pancreatic cancer.
South Florida's Sylvester Comprehensive Cancer Center: Hitting Its Stride
The Sylvester Comprehensive Cancer Center (SCCC), part of the University of Miami Health System, first opened its doors in 1992. Over the years, the SCCC has become the hub of cancer research in the region.
Isa-KRd Elicits MRD-Negative Remissions in Newly Diagnosed, High-Risk Myeloma
KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis
Smoldering Multiple Myeloma Management Hinges on the Debate Between Treatment and Observation
Lung Responses to Atezolizumab/Bevacizumab Linked With OS in HCC and Pulmonary Metastasis
2 Clarke Drive Cranbury, NJ 08512